Nutrient overload, lipid peroxidation and pancreatic beta cell function

Free Radical Biology and Medicine

Volumn 111, Issue , 2017, Pages 102-109

  Sasson, Shlomo ^a  

^a HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

4 Hydroxynonenal; Beta cells; Diabetes; Lipid peroxidation; Lipohormesis; Lipotoxicity

Indexed keywords

LIPID; PHOSPHOLIPASE A2; POLYUNSATURATED FATTY ACID; 4-HYDROXY-2-NONENAL; ADVANCED GLYCATION END PRODUCT; ALDEHYDE;

HUMAN; LIPID PEROXIDATION; METABOLITE; NONHUMAN; NUTRIENT; PANCREAS ISLET CELL FUNCTION; PRIORITY JOURNAL; REVIEW; SIGNAL TRANSDUCTION; ANIMAL; DIABETIC NEUROPATHY; HORMESIS; HYPERGLYCEMIA; HYPERLIPIDEMIA; INSULIN RESISTANCE; METABOLISM; NON INSULIN DEPENDENT DIABETES MELLITUS; OXIDATIVE STRESS; PANCREAS ISLET BETA CELL; PATHOLOGY;

ALDEHYDES; ANIMALS; DIABETES MELLITUS, TYPE 2; DIABETIC NEUROPATHIES; GLYCATION END PRODUCTS, ADVANCED; HORMESIS; HUMANS; HYPERGLYCEMIA; HYPERLIPIDEMIAS; INSULIN RESISTANCE; INSULIN-SECRETING CELLS; LIPID PEROXIDATION; OXIDATIVE STRESS; PHOSPHOLIPASES A2;

EID: 85011088506     PISSN: 08915849     EISSN: 18734596     Source Type: Journal    
DOI: 10.1016/j.freeradbiomed.2016.09.003     Document Type: Review

References (128)

1. Alejandro, E.U., Gregg, B., Blandino-Rosano, M., Cras-Meneur, C., Bernal-Mizrachi, E., Natural history of beta-cell adaptation and failure in type 2 diabetes. Mol. Asp. Med. 42 (2015), 19–41.
2. Maulucci, G., Daniel, B., Cohen, O., Avrahami, Y., Sasson, S., Hormetic and regulatory effects of lipid peroxidation mediators in pancreatic beta cells. Mol. Asp. Med. 49 (2016), 49–77.
3. Nathan, D.M., Long-term complications of diabetes mellitus. N. Engl. J. Med. 328:23 (1993), 1676–1685.
4. Bailes, B.K., Diabetes mellitus and its chronic complications. AORN J. 76:2 (2002), 266–276 278-82; quiz 283-286.
5. Giacco, F., Brownlee, M., Oxidative stress and diabetic complications. Circ. Res. 107:9 (2010), 1058–1070.
6. Aronson, D., Hyperglycemia and the pathobiology of diabetic complications. Adv. Cardiol. 45 (2008), 1–16.
7. Aronson, D., Rayfield, E.J., How hyperglycemia promotes atherosclerosis: molecular mechanisms. Cardiovasc. Diabetol., 1, 2002, 1.
8. Sayin, N., Kara, N., Pekel, G., Ocular complications of diabetes mellitus. World J. Diabetes 6:1 (2015), 92–108.
9. Forbes, J.M., Cooper, M.E., Mechanisms of diabetic complications. Physiol. Rev. 93:1 (2013), 137–188.
10. Forman, H.J., Redox signaling: an evolution from free radicals to aging. Free Radic. Biol. Med. 97 (2016), 398–407.
11. Lu, M.C., Ji, J.A., Jiang, Z.Y., You, Q.D., The keap1-Nrf2-ARE pathway as a potential preventive and therapeutic target: an update. Med. Res. Rev., 2016.
12. Davies, K.J., Adaptive homeostasis. Mol. Asp. Med. 49 (2016), 1–7.
13. Haeiwa, H., Fujita, T., Saitoh, Y., Miwa, N., Oleic acid promotes adaptability against oxidative stress in 3T3-L1 cells through lipohormesis. Mol. Cell. Biochem. 386:1–2 (2014), 73–83.
14. Nolan, C.J., Larter, C.Z., Lipotoxicity: why do saturated fatty acids cause and monounsaturates protect against it?. J. Gastroenterol. Hepatol. 24:5 (2009), 703–706.
15. Sommerweiss, D., Gorski, T., Richter, S., Garten, A., Kiess, W., Oleate rescues INS-1E beta-cells from palmitate-induced apoptosis by preventing activation of the unfolded protein response. Biochem. Biophys. Res. Commun. 441:4 (2013), 770–776.
16. Tuo, Y., Feng, D.D., Wang, D.F., Sun, J., Li, S.B., Chen, C., Long-term in vitro treatment of INS-1 rat pancreatic beta-cells by unsaturated free fatty acids protects cells against gluco- and lipotoxicities via activation of GPR40 receptors. Clin. Exp. Pharmacol. Physiol. 39:5 (2012), 423–428.
17. Maedler, K., Spinas, G.A., Dyntar, D., Moritz, W., Kaiser, N., Donath, M.Y., Distinct effects of saturated and monounsaturated fatty acids on beta-cell turnover and function. Diabetes 50:1 (2001), 69–76.
18. Hanke, D., Zahradka, P., Mohankumar, S.K., Clark, J.L., Taylor, C.G., A diet high in alpha-linolenic acid and monounsaturated fatty acids attenuates hepatic steatosis and alters hepatic phospholipid fatty acid profile in diet-induced obese rats. Prostaglandins Leukot. Essent. Fat. Acids 89:6 (2013), 391–401.
19. Schaur, R.J., Siems, W., Bresgen, N., Eckl, P.M., 4-Hydroxy-nonenal-A bioactive lipid peroxidation product. Biomolecules 5:4 (2015), 2247–2337.
20. Poli, G., Biasi, F., Leonarduzzi, G., 4-Hydroxynonenal-protein adducts: a reliable biomarker of lipid oxidation in liver diseases. Mol. Asp. Med. 29:1–2 (2008), 67–71.
21. Hu, W., Feng, Z., Eveleigh, J., Iyer, G., Pan, J., Amin, S., Chung, F.L., Tang, M.S., The major lipid peroxidation product, trans-4-hydroxy-2-nonenal, preferentially forms DNA adducts at codon 249 of human p53 gene, a unique mutational hotspot in hepatocellular carcinoma. Carcinogenesis 23:11 (2002), 1781–1789.
22. Bacot, S., Bernoud-Hubac, N., Chantegrel, B., Deshayes, C., Doutheau, A., Ponsin, G., Lagarde, M., Guichardant, M., Evidence for in situ ethanolamine phospholipid adducts with hydroxy-alkenals. J. Lipid Res. 48:4 (2007), 816–825.
23. Rudic, M., Keogh, I., Wagner, R., Wilkinson, E., Kiros, N., Ferrary, E., Sterkers, O., Grayeli, A. Bozorg, Zarkovic, K., Zarkovic, N., The pathophysiology of otosclerosis: review of current research. Hear. Res. 330:Pt A (2015), 51–56.
24. Stepanic, V., Gasparovic, A.C., Troselj, K.G., Amic, D., Zarkovic, N., Selected attributes of polyphenols in targeting oxidative stress in cancer. Curr. Top. Med. Chem. 15:5 (2015), 496–509.
25. Jaganjac, M., Tirosh, O., Cohen, G., Sasson, S., Zarkovic, N., Reactive aldehydes–second messengers of free radicals in diabetes mellitus. Free Radic. Res. 47:Suppl. 1 (2013), S39–S48.
26. Negre-Salvayre, A., Auge, N., Ayala, V., Basaga, H., Boada, J., Brenke, R., Chapple, S., Cohen, G., Feher, J., Grune, T., Lengyel, G., Mann, G.E., Pamplona, R., Poli, G., Portero-Otin, M., Riahi, Y., Salvayre, R., Sasson, S., Serrano, J., Shamni, O., Siems, W., Siow, R.C., Wiswedel, I., Zarkovic, K., Zarkovic, N., Pathological aspects of lipid peroxidation. Free Radic. Res. 44:10 (2010), 1125–1171.
27. Esterbauer, H., Schaur, R.J., Zollner, H., Chemistry and biochemistry of 4-hydroxynonenal, malonaldehyde and related aldehydes. Free Radic. Biol. Med. 11:1 (1991), 81–128.
28. Cohen, G., Shamni, O., Avrahami, Y., Cohen, O., Broner, E.C., Filippov-Levy, N., Chatgilialoglu, C., Ferreri, C., Kaiser, N., Sasson, S., Beta cell response to nutrient overload involves phospholipid remodelling and lipid peroxidation. Diabetologia 58:6 (2015), 1333–1343.
29. Manea, A., Manea, S.A., Todirita, A., Albulescu, I.C., Raicu, M., Sasson, S., Simionescu, M., High-glucose-increased expression and activation of NADPH oxidase in human vascular smooth muscle cells is mediated by 4-hydroxynonenal-activated PPARalpha and PPARbeta/delta. Cell Tissue Res. 361:2 (2015), 593–604.
30. Cohen, G., Riahi, Y., Shamni, O., Guichardant, M., Chatgilialoglu, C., Ferreri, C., Kaiser, N., Sasson, S., Role of lipid peroxidation and PPAR-delta in amplifying glucose-stimulated insulin secretion. Diabetes 60:11 (2011), 2830–2842.
31. Riahi, Y., Sin-Malia, Y., Cohen, G., Alpert, E., Gruzman, A., Eckel, J., Staels, B., Guichardant, M., Sasson, S., The natural protective mechanism against hyperglycemia in vascular endothelial cells: roles of the lipid peroxidation product 4-hydroxydodecadienal and peroxisome proliferator-activated receptor delta. Diabetes 59:4 (2010), 808–818.
32. Coleman, J.D., Prabhu, K.S., Thompson, J.T., Reddy, P.S., Peters, J.M., Peterson, B.R., Reddy, C.C., Vanden Heuvel, J.P., The oxidative stress mediator 4-hydroxynonenal is an intracellular agonist of the nuclear receptor peroxisome proliferator-activated receptor-beta/delta (PPARbeta/delta). Free Radic. Biol. Med. 42:8 (2007), 1155–1164.
33. Bezard, J., Blond, J.P., Bernard, A., Clouet, P., The metabolism and availability of essential fatty acids in animal and human tissues. Reprod. Nutr. Dev. 34:6 (1994), 539–568.
34. Yamashita, A., Hayashi, Y., Matsumoto, N., Nemoto-Sasaki, Y., Oka, S., Tanikawa, T., Sugiura, T., Glycerophosphate/Acylglycerophosphate acyltransferases. Biology 3:4 (2014), 801–830.
35. Ramanadham, S., Bohrer, A., Mueller, M., Jett, P., Gross, R.W., Turk, J., Mass spectrometric identification and quantitation of arachidonate-containing phospholipids in pancreatic islets: prominence of plasmenylethanolamine molecular species. Biochemistry 32:20 (1993), 5339–5351.
36. MacDonald, M.J., Ade, L., Ntambi, J.M., Ansari, I.U., Stoker, S.W., Characterization of phospholipids in insulin secretory granules and mitochondria in pancreatic beta cells and their changes with glucose stimulation. J. Biol. Chem. 290:17 (2015), 11075–11092.
37. Aoyagi, K., Ohara-Imaizumi, M., Nagamatsu, S., Regulation of resident and newcomer insulin granules by calcium and SNARE proteins. Front. Biosci. 16 (2011), 1197–1210 (Landmark Ed).
38. Parker, K.J., Jones, P.M., Hunton, C.H., Persaud, S.J., Taylor, C.G., Howell, S.L., Identification and localisation of a type IV cytosolic phospholipase A2 in rat pancreatic beta-cells. J. Mol. Endocrinol. 17:1 (1996), 31–43.
39. Juhl, K., Hoy, M., Olsen, H.L., Bokvist, K., Efanov, A.M., Hoffmann, E.K., Gromada, J., cPLA2alpha-evoked formation of arachidonic acid and lysophospholipids is required for exocytosis in mouse pancreatic beta-cells. Am. J. Physiol. Endocrinol. Metab. 285:1 (2003), E73–E81.
40. Jolly, Y.C., Major, C., Wolf, B.A., Transient activation of calcium-dependent phospholipase A2 by insulin secretagogues in isolated pancreatic islets. Biochemistry 32:45 (1993), 12209–12217.
41. Buczynski, M.W., Dumlao, D.S., Dennis, E.A., Thematic review series: proteomics. An integrated omics analysis of eicosanoid biology. J. Lipid Res. 50:6 (2009), 1015–1038.
42. Kudo, I., Murakami, M., Phospholipase A2 enzymes. Prostaglandins Other Lipid Mediat 68–69 (2002), 3–58.
43. Leslie, C.C., Cytosolic phospholipase A(2): physiological function and role in disease. J. Lipid Res. 56:8 (2015), 1386–1402.
44. Pavicevic, Z., Leslie, C.C., Malik, K.U., cPLA2 phosphorylation at serine-515 and serine-505 is required for arachidonic acid release in vascular smooth muscle cells. J. Lipid Res. 49:4 (2008), 724–737.
45. Asfari, M., Janjic, D., Meda, P., Li, G., Halban, P.A., Wollheim, C.B., Establishment of 2-mercaptoethanol-dependent differentiated insulin-secreting cell lines. Endocrinology 130:1 (1992), 167–178.
46. Chen, M., Yang, Z., Naji, A., Wolf, B.A., Identification of calcium-dependent phospholipase A2 isoforms in human and rat pancreatic islets and insulin secreting beta-cell lines. Endocrinology 137:7 (1996), 2901–2909.
47. Loweth, A.C., Scarpello, J.H., Morgan, N.G., Phospholipase A2 expression in human and rodent insulin-secreting cells. Mol. Cell. Endocrinol. 112:2 (1995), 177–183.
48. Loweth, A.C., Scarpello, J.H., Morgan, N.G., A comparison of cytosolic phospholipase A2 expression in human islets of Langerhans and rodent insulin-secreting cells. Biochem. Soc. Trans., 22(4), 1994, 430S.
49. Caporarello, N., Salmeri, M., Scalia, M., Motta, C., Parrino, C., Frittitta, L., Olivieri, M., Toscano, M.A., Anfuso, C.D., Lupo, G., Role of cytosolic and calcium independent phospholipases A(2) in insulin secretion impairment of INS-1E cells infected by S. aureus. FEBS Lett. 589:24 Pt B (2015), 3969–3976.
50. Bao, S., Jacobson, D.A., Wohltmann, M., Bohrer, A., Jin, W., Philipson, L.H., Turk, J., Glucose homeostasis, insulin secretion, and islet phospholipids in mice that overexpress iPLA2beta in pancreatic beta-cells and in iPLA2beta-null mice. Am. J. Physiol. Endocrinol. Metab. 294:2 (2008), E217–E229.
51. Bao, S., Bohrer, A., Ramanadham, S., Jin, W., Zhang, S., Turk, J., Effects of stable suppression of Group VIA phospholipase A2 expression on phospholipid content and composition, insulin secretion, and proliferation of INS-1 insulinoma cells. J. Biol. Chem. 281:1 (2006), 187–198.
52. Riahi, Y., Cohen, G., Shamni, O., Sasson, S., Signaling and cytotoxic functions of 4-hydroxyalkenals. Am. J. Physiol. Endocrinol. Metab. 299:6 (2010), E879–E886.
53. Cohen, G., Riahi, Y., Sunda, V., Deplano, S., Chatgilialoglu, C., Ferreri, C., Kaiser, N., Sasson, S., Signaling properties of 4-hydroxyalkenals formed by lipid peroxidation in diabetes. Free Radic. Biol. Med. 65 (2013), 978–987.
54. Imai, Y., Dobrian, A.D., Morris, M.A., Taylor-Fishwick, D.A., Nadler, J.L., Lipids and immunoinflammatory pathways of beta cell destruction. Diabetologia 59:4 (2016), 673–678.
55. Kimple, M.E., Neuman, J.C., Linnemann, A.K., Casey, P.J., Inhibitory G proteins and their receptors: emerging therapeutic targets for obesity and diabetes. Exp. Mol. Med., 46, 2014, e102.
56. Klett, E.L., Chen, S., Edin, M.L., Li, L.O., Ilkayeva, O., Zeldin, D.C., Newgard, C.B., Coleman, R.A., Diminished acyl-CoA synthetase isoform 4 activity in INS 832/13 cells reduces cellular epoxyeicosatrienoic acid levels and results in impaired glucose-stimulated insulin secretion. J. Biol. Chem. 288:30 (2013), 21618–21629.
57. Luo, P., Wang, M.H., Eicosanoids, beta-cell function, and diabetes. Prostaglandins Other Lipid Mediat. 95:1–4 (2011), 1–10.
58. Zafiriou, M.P., Zelarayan, L.C., Noack, C., Renger, A., Nigam, S., Siafaka-Kapadai, A., Hepoxilin A(3) protects beta-cells from apoptosis in contrast to its precursor, 12-hydroperoxyeicosatetraenoic acid. Biochim. Biophys. Acta 1811:6 (2011), 361–369.
59. Persaud, S.J., Muller, D., Belin, V.D., Papadimitriou, A., Huang, G.C., Amiel, S.A., Jones, P.M., Expression and function of cyclooxygenase and lipoxygenase enzymes in human islets of Langerhans. Arch. Physiol. Biochem. 113:3 (2007), 104–109.
60. Akpan, J.O., Hurley, M.C., Pek, S., Lands, W.E., The effects of prostaglandins on secretion of glucagon and insulin by the perfused rat pancreas. Can. J. Biochem. 57:6 (1979), 540–547.
61. Fezza, F., Bari, M., Florio, R., Talamonti, E., Feole, M., Maccarrone, M., Endocannabinoids, related compounds and their metabolic routes. Molecules 19:11 (2014), 17078–17106.
62. Jourdan, T., Godlewski, G., Kunos, G., Endocannabinoid regulation of beta-cell functions: implications for glycaemic control and diabetes. Diabetes Obes. Metab. 18:6 (2016), 549–557.
63. Spivak, C.E., Kim, W., Liu, Q.R., Lupica, C.R., Doyle, M.E., Blockade of beta-cell K(ATP) channels by the endocannabinoid, 2-arachidonoylglycerol. Biochem. Biophys. Res. Commun. 423:1 (2012), 13–18.
64. Li, C., Bowe, J.E., Jones, P.M., Persaud, S.J., Expression and function of cannabinoid receptors in mouse islets. Islets 2:5 (2010), 293–302.
65. Miwa, I., Ichimura, N., Sugiura, M., Hamada, Y., Taniguchi, S., Inhibition of glucose-induced insulin secretion by 4-hydroxy-2-nonenal and other lipid peroxidation products. Endocrinology 141:8 (2000), 2767–2772.
66. Singh, S.P., Niemczyk, M., Saini, D., Awasthi, Y.C., Zimniak, L., Zimniak, P., Role of the electrophilic lipid peroxidation product 4-hydroxynonenal in the development and maintenance of obesity in mice. Biochemistry 47:12 (2008), 3900–3911.
67. Zarkovic, N., Cipak, A., Jaganjac, M., Borovic, S., Zarkovic, K., Pathophysiological relevance of aldehydic protein modifications. J. Proteom. 92 (2013), 239–247.
68. Higdon, A., Diers, A.R., Oh, J.Y., Landar, A., Darley-Usmar, V.M., Cell signalling by reactive lipid species: new concepts and molecular mechanisms. Biochem. J. 442:3 (2012), 453–464.
69. Poli, G., Schaur, R.J., Siems, W.G., Leonarduzzi, G., 4-hydroxynonenal: a membrane lipid oxidation product of medicinal interest. Med. Res. Rev. 28:4 (2008), 569–631.
70. Schneider, C., Tallman, K.A., Porter, N.A., Brash, A.R., Two distinct pathways of formation of 4-hydroxynonenal. Mechanisms of nonenzymatic transformation of the 9- and 13-hydroperoxides of linoleic acid to 4-hydroxyalkenals. J. Biol. Chem. 276:24 (2001), 20831–20838.
71. Niki, E., Yoshida, Y., Saito, Y., Noguchi, N., Lipid peroxidation: mechanisms, inhibition, and biological effects. Biochem. Biophys. Res. Commun. 338:1 (2005), 668–676.
72. Pryor, W.A., Porter, N.A., Suggested mechanisms for the production of 4-hydroxy-2-nonenal from the autoxidation of polyunsaturated fatty acids. Free Radic. Biol. Med. 8:6 (1990), 541–543.
73. Schneider, C., An update on products and mechanisms of lipid peroxidation. Mol. Nutr. Food Res. 53:3 (2009), 315–321.
74. Schneider, C., Porter, N.A., Brash, A.R., Routes to 4-hydroxynonenal: fundamental issues in the mechanisms of lipid peroxidation. J. Biol. Chem. 283:23 (2008), 15539–15543.
75. Tejero, I., Gonzalez-Lafont, A., Lluch, J.M., Eriksson, L.A., Theoretical modeling of hydroxyl-radical-induced lipid peroxidation reactions. J. Phys. Chem. B 111:20 (2007), 5684–5693.
76. Uchida, K., 4-Hydroxy-2-nonenal: a product and mediator of oxidative stress. Prog. Lipid Res. 42:4 (2003), 318–343.
77. Ayala, A., Munoz, M.F., Arguelles, S., Lipid peroxidation: production, metabolism, and signaling mechanisms of malondialdehyde and 4-hydroxy-2-nonenal. Oxid. Med. Cell. Longev., 2014, 2014, 360438.
78. Yin, H., Xu, L., Porter, N.A., Free radical lipid peroxidation: mechanisms and analysis. Chem. Rev. 111:10 (2011), 5944–5972.
79. Guichardant, M., Bacot, S., Moliere, P., Lagarde, M., Hydroxy-alkenals from the peroxidation of n-3 and n-6 fatty acids and urinary metabolites. Prostaglandins Leukot. Essent. Fat. Acids 75:3 (2006), 179–182.
80. Bacot, S., Bernoud-Hubac, N., Baddas, N., Chantegrel, B., Deshayes, C., Doutheau, A., Lagarde, M., Guichardant, M., Covalent binding of hydroxy-alkenals 4-HDDE, 4-HHE, and 4-HNE to ethanolamine phospholipid subclasses. J. Lipid Res. 44:5 (2003), 917–926.
81. Toyokuni, S., Yamada, S., Kashima, M., Ihara, Y., Yamada, Y., Tanaka, T., Hiai, H., Seino, Y., Uchida, K., Serum 4-hydroxy-2-nonenal-modified albumin is elevated in patients with type 2 diabetes mellitus. Antioxid. Redox Signal. 2:4 (2000), 681–685.
82. Hubatsch, I., Ridderstrom, M., Mannervik, B., Human glutathione transferase A4-4: an alpha class enzyme with high catalytic efficiency in the conjugation of 4-hydroxynonenal and other genotoxic products of lipid peroxidation. Biochem. J. 330:Pt 1 (1998), 175–179.
83. Curtis, J.M., Grimsrud, P.A., Wright, W.S., Xu, X., Foncea, R.E., Graham, D.W., Brestoff, J.R., Wiczer, B.M., Ilkayeva, O., Cianflone, K., Muoio, D.E., Arriaga, E.A., Bernlohr, D.A., Downregulation of adipose glutathione S-transferase A4 leads to increased protein carbonylation, oxidative stress, and mitochondrial dysfunction. Diabetes 59:5 (2010), 1132–1142.
84. Vaillancourt, F., Fahmi, H., Shi, Q., Lavigne, P., Ranger, P., Fernandes, J.C., Benderdour, M., 4-Hydroxynonenal induces apoptosis in human osteoarthritic chondrocytes: the protective role of glutathione-S-transferase. Arthritis Res. Ther., 10(5), 2008, R107.
85. Koulajian, K., Ivovic, A., Ye, K., Desai, T., Shah, A., Fantus, I.G., Ran, Q., Giacca, A., Overexpression of glutathione peroxidase 4 prevents beta-cell dysfunction induced by prolonged elevation of lipids in vivo. Am. J. Physiol. Endocrinol. Metab. 305:2 (2013), E254–E262.
86. Zhou, S., Decker, E.A., Ability of carnosine and other skeletal muscle components to quench unsaturated aldehydic lipid oxidation products. J. Agric. Food Chem. 47:1 (1999), 51–55.
87. Guiotto, A., Calderan, A., Ruzza, P., Borin, G., Carnosine and carnosine-related antioxidants: a review. Curr. Med. Chem. 12:20 (2005), 2293–2315.
88. Regazzoni, L., de Courten, B., Garzon, D., Altomare, A., Marinello, C., Jakubova, M., Vallova, S., Krumpolec, P., Carini, M., Ukropec, J., Ukropcova, B., Aldini, G., A carnosine intervention study in overweight human volunteers: bioavailability and reactive carbonyl species sequestering effect. Sci. Rep., 6, 2016, 27224.
89. Pizzimenti, S., Ciamporcero, E., Daga, M., Pettazzoni, P., Arcaro, A., Cetrangolo, G., Minelli, R., Dianzani, C., Lepore, A., Gentile, F., Barrera, G., Interaction of aldehydes derived from lipid peroxidation and membrane proteins. Front. Physiol., 4, 2013, 242.
90. Demozay, D., Rocchi, S., Mas, J.C., Grillo, S., Pirola, L., Chavey, C., Obberghen, E. Van, Fatty aldehyde dehydrogenase: potential role in oxidative stress protection and regulation of its gene expression by insulin. J. Biol. Chem. 279:8 (2004), 6261–6270.
91. Tersey, S.A., Bolanis, E., Holman, T.R., Maloney, D.J., Nadler, J.L., Mirmira, R.G., Minireview: 12-lipoxygenase and islet beta-cell dysfunction in diabetes. Mol. Endocrinol. 29:6 (2015), 791–800.
92. Csala, M., Kardon, T., Legeza, B., Lizak, B., Mandl, J., Margittai, E., Puskas, F., Szaraz, P., Szelenyi, P., Banhegyi, G., On the role of 4-hydroxynonenal in health and disease. Biochim. Biophys. Acta 1852:5 (2015), 826–838.
93. Domingues, R.M., Domingues, P., Melo, T., Perez-Sala, D., Reis, A., Spickett, C.M., Lipoxidation adducts with peptides and proteins: deleterious modifications or signaling mechanisms?. J. Proteom. 92 (2013), 110–131.
94. Forman, H.J., Reactive oxygen species and alpha,beta-unsaturated aldehydes as second messengers in signal transduction. Ann. N. Y. Acad. Sci. 1203 (2010), 35–44.
95. Chaudhary, P., Sharma, R., Sharma, A., Vatsyayan, R., Yadav, S., Singhal, S.S., Rauniyar, N., Prokai, L., Awasthi, S., Awasthi, Y.C., Mechanisms of 4-hydroxy-2-nonenal induced pro- and anti-apoptotic signaling. Biochemistry 49:29 (2010), 6263–6275.
96. Awasthi, Y.C., Sharma, R., Sharma, A., Yadav, S., Singhal, S.S., Chaudhary, P., Awasthi, S., Self-regulatory role of 4-hydroxynonenal in signaling for stress-induced programmed cell death. Free Radic. Biol. Med. 45:2 (2008), 111–118.
97. Zarrouki, B., Soares, A.F., Guichardant, M., Lagarde, M., Geloen, A., The lipid peroxidation end-product 4-HNE induces COX-2 expression through p38MAPK activation in 3T3-L1 adipose cell. FEBS Lett. 581:13 (2007), 2394–2400.
98. Sampey, B.P., Carbone, D.L., Doorn, J.A., Drechsel, D.A., Petersen, D.R., 4-Hydroxy-2-nonenal adduction of extracellular signal-regulated kinase (Erk) and the inhibition of hepatocyte Erk-Est-like protein-1-activating protein-1 signal transduction. Mol. Pharmacol. 71:3 (2007), 871–883.
99. Castello, L., Marengo, B., Nitti, M., Froio, T., Domenicotti, C., Biasi, F., Leonarduzzi, G., Pronzato, M.A., Marinari, U.M., Poli, G., Chiarpotto, E., 4-Hydroxynonenal signalling to apoptosis in isolated rat hepatocytes: the role of PKC-delta. Biochim. Biophys. Acta 1737:2–3 (2005), 83–93.
100. Benderdour, M., Charron, G., Comte, B., Ayoub, R., Beaudry, D., Foisy, S., Deblois, D., Des Rosiers, C., Decreased cardiac mitochondrial NADP+-isocitrate dehydrogenase activity and expression: a marker of oxidative stress in hypertrophy development. Am. J. Physiol. Heart Circ. Physiol. 287:5 (2004), H2122–H2131.
101. Benderdour, M., Charron, G., DeBlois, D., Comte, B., Des Rosiers, C., Cardiac mitochondrial NADP+-isocitrate dehydrogenase is inactivated through 4-hydroxynonenal adduct formation: an event that precedes hypertrophy development. J. Biol. Chem. 278:46 (2003), 45154–45159.
102. Echtay, K.S., Esteves, T.C., Pakay, J.L., Jekabsons, M.B., Lambert, A.J., Portero-Otin, M., Pamplona, R., Vidal-Puig, A.J., Wang, S., Roebuck, S.J., Brand, M.D., A signalling role for 4-hydroxy-2-nonenal in regulation of mitochondrial uncoupling. EMBO J. 22:16 (2003), 4103–4110.
103. Hoff, H.F., O'Neil, J., Wu, Z., Hoppe, G., Salomon, R.L., Phospholipid hydroxyalkenals: biological and chemical properties of specific oxidized lipids present in atherosclerotic lesions. Arterioscler. Thromb. Vasc. Biol. 23:2 (2003), 275–282.
104. Chiarpotto, E., Domenicotti, C., Paola, D., Vitali, A., Nitti, M., Pronzato, M.A., Biasi, F., Cottalasso, D., Marinari, U.M., Dragonetti, A., Cesaro, P., Isidoro, C., Poli, G., Regulation of rat hepatocyte protein kinase C beta isoenzymes by the lipid peroxidation product 4-hydroxy-2,3-nonenal: a signaling pathway to modulate vesicular transport of glycoproteins. Hepatology 29:5 (1999), 1565–1572.
105. Chen, J., Schenker, S., Frosto, T.A., Henderson, G.I., Inhibition of cytochrome c oxidase activity by 4-hydroxynonenal (HNE). Role of HNE adduct formation with the enzyme subunits. Biochim. Biophys. Acta 1380:3 (1998), 336–344.
106. Humphries, K.M., Yoo, Y., Szweda, L.I., Inhibition of NADH-linked mitochondrial respiration by 4-hydroxy-2-nonenal. Biochemistry 37:2 (1998), 552–557.
107. Chen, J.J., Bertrand, H., Yu, B.P., Inhibition of adenine nucleotide translocator by lipid peroxidation products. Free Radic. Biol. Med. 19:5 (1995), 583–590.
108. Hoff, H.F., O'Neil, J., Structural and functional changes in LDL after modification with both 4-hydroxynonenal and malondialdehyde. J. Lipid Res. 34:7 (1993), 1209–1217.
109. McMahon, M., Lamont, D.J., Beattie, K.A., Hayes, J.D., Keap1 perceives stress via three sensors for the endogenous signaling molecules nitric oxide, zinc, and alkenals. Proc. Natl. Acad. Sci. USA 107:44 (2010), 18838–18843.
110. Levonen, A.L., Hill, B.G., Kansanen, E., Zhang, J., Darley-Usmar, V.M., Redox regulation of antioxidants, autophagy, and the response to stress: implications for electrophile therapeutics. Free Radic. Biol. Med. 71 (2014), 196–207.
111. Kobayashi, M., Li, L., Iwamoto, N., Nakajima-Takagi, Y., Kaneko, H., Nakayama, Y., Eguchi, M., Wada, Y., Kumagai, Y., Yamamoto, M., The antioxidant defense system Keap1-Nrf2 comprises a multiple sensing mechanism for responding to a wide range of chemical compounds. Mol. Cell. Biol. 29:2 (2009), 493–502.
112. Lin, M.H., Yen, J.H., Weng, C.Y., Wang, L., Ha, C.L., Wu, M.J., Lipid peroxidation end product 4-hydroxy-trans-2-nonenal triggers unfolded protein response and heme oxygenase-1 expression in PC12 cells: roles of ROS and MAPK pathways. Toxicology 315 (2014), 24–37.
113. Schafer, M., Werner, S., Nrf2-A regulator of keratinocyte redox signaling. Free Radic. Biol. Med. 88:Pt B (2015), 243–252.
114. Lee, S.J., Kim, C.E., Seo, K.W., Kim, C.D., HNE-induced 5-LO expression is regulated by NF-{kappa}B/ERK and Sp1/p38 MAPK pathways via EGF receptor in murine macrophages. Cardiovasc. Res. 88:2 (2010), 352–359.
115. Lee, S.J., Seo, K.W., Yun, M.R., Bae, S.S., Lee, W.S., Hong, K.W., Kim, C.D., 4-Hydroxynonenal enhances MMP-2 production in vascular smooth muscle cells via mitochondrial ROS-mediated activation of the Akt/NF-kappaB signaling pathways. Free Radic. Biol. Med. 45:10 (2008), 1487–1492.
116. Hattori, Y., Hattori, S., Kasai, K., 4-hydroxynonenal prevents NO production in vascular smooth muscle cells by inhibiting nuclear factor-kappaB-dependent transcriptional activation of inducible NO synthase. Arterioscler. Thromb. Vasc. Biol. 21:7 (2001), 1179–1183.
117. Page, S., Fischer, C., Baumgartner, B., Haas, M., Kreusel, U., Loidl, G., Hayn, M., Ziegler-Heitbrock, H.W., Neumeier, D., Brand, K., 4-Hydroxynonenal prevents NF-kappaB activation and tumor necrosis factor expression by inhibiting IkappaB phosphorylation and subsequent proteolysis. J. Biol. Chem. 274:17 (1999), 11611–11618.
118. Gehrmann, W., Elsner, M., Lenzen, S., Role of metabolically generated reactive oxygen species for lipotoxicity in pancreatic beta-cells. Diabetes Obes. Metab. 12:Suppl. 2 (2010), S149–S158.
119. Lenzen, S., Oxidative stress: the vulnerable beta-cell. Biochem. Soc. Trans. 36:Pt 3 (2008), 343–347.
120. Lenzen, S., Drinkgern, J., Tiedge, M., Low antioxidant enzyme gene expression in pancreatic islets compared with various other mouse tissues. Free Radic. Biol. Med. 20:3 (1996), 463–466.
121. Totary-Jain, H., Naveh-Many, T., Riahi, Y., Kaiser, N., Eckel, J., Sasson, S., Calreticulin destabilizes glucose transporter-1 mRNA in vascular endothelial and smooth muscle cells under high-glucose conditions. Circ. Res. 97:10 (2005), 1001–1008.
122. Ferrannini, E., Gastaldelli, A., Iozzo, P., Pathophysiology of prediabetes. Med. Clin. N. Am. 95:2 (2011), 327–339 (vii-viii).
123. Weir, G.C., Bonner-Weir, S., Five stages of evolving beta-cell dysfunction during progression to diabetes. Diabetes 53:Suppl. 3 (2004), S16–S21.
124. Benedetti, E., D'Angelo, B., Cristiano, L., Di Giacomo, E., Fanelli, F., Moreno, S., Cecconi, F., Fidoamore, A., Antonosante, A., Falcone, R., Ippoliti, R., Giordano, A., Cimini, A., Involvement of peroxisome proliferator-activated receptor beta/delta (PPAR beta/delta) in BDNF signaling during aging and in Alzheimer disease: possible role of 4-hydroxynonenal (4-HNE). Cell Cycle 13:8 (2014), 1335–1344.
125. Ravnskjaer, K., Frigerio, F., Boergesen, M., Nielsen, T., Maechler, P., Mandrup, S., PPARdelta is a fatty acid sensor that enhances mitochondrial oxidation in insulin-secreting cells and protects against fatty acid-induced dysfunction. J. Lipid Res. 51:6 (2010), 1370–1379.
126. Cnop, M., Fatty acids and glucolipotoxicity in the pathogenesis of Type 2 diabetes. Biochem. Soc. Trans. 36:Pt 3 (2008), 348–352.
127. Alhazmi, A., Stojanovski, E., Garg, M.L., McEvoy, M., Fasting whole blood fatty acid profile and risk of type 2 diabetes in adults: a nested case control study. PLoS One, 9(5), 2014, e97001.
128. Kurotani, K., Sato, M., Ejima, Y., Nanri, A., Yi, S., Pham, N.M., Akter, S., Poudel-Tandukar, K., Kimura, Y., Imaizumi, K., Mizoue, T., High levels of stearic acid, palmitoleic acid, and dihomo-gamma-linolenic acid and low levels of linoleic acid in serum cholesterol ester are associated with high insulin resistance. Nutr. Res. 32:9 (2012), 669–675 e3.